Thromboangiitis obliterans (Buerger's disease)

Area of Science:

• Vascular Inflammation
• Rheumatology
• Tobacco-Related Diseases

Background:

• Thromboangiitis Obliterans (TAO) is a rare, non-atherosclerotic inflammatory vasculitis.
• The exact etiology remains unknown, but a strong association with tobacco use is established.
• TAO primarily affects small and medium-sized arteries and veins in the limbs.

Purpose of the Study:

• To present current concepts on the pathophysiology of Thromboangiitis Obliterans.
• To review diagnostic approaches for TAO.
• To provide an overview of existing and emerging treatment strategies for TAO.

Main Methods:

• Literature review of existing studies on Thromboangiitis Obliterans.
• Synthesis of current understanding regarding TAO pathophysiology.
• Compilation of diagnostic criteria and imaging findings.
• Review of therapeutic interventions, including medical and surgical options.

Main Results:

• Pathophysiology involves inflammation and thrombosis of blood vessels, strongly linked to tobacco.
• Diagnosis relies on clinical presentation, exclusion of other conditions, and characteristic vascular findings.
• Treatment focuses on smoking cessation, alongside antiplatelet agents, vasodilators, and potentially advanced therapies.

Conclusions:

• Thromboangiitis Obliterans requires prompt diagnosis and aggressive management, centered on complete smoking cessation.
• Understanding the pathophysiology is crucial for developing targeted treatments.
• Further research is needed to elucidate the etiology and improve therapeutic outcomes for TAO patients.